BIMI Holdings Inc.

BIMI

US05552Q3011

Pharmaceuticals

Delayed Nasdaq Other stock markets 19:06:56 20/05/2024 BST			5-day change	1st Jan Change
1.38 ^USD	+9.52%		+27.79%	-36.99%

03-05	Top Premarket Decliners	MT
01-05	BIMI International Medical, Inc. Announces Management Appointments	CI

Fengsheng Tan to Resign as Director of BIMI International Medical Inc

March 07, 2022 at 09:31 pm

On March 6, 2022, Mr. Fengsheng Tan notified BIMI International Medical Inc. of his intent to resign as a director of the Company effective immediately for personal reasons.

Latest news about BIMI Holdings Inc.

Top Premarket Decliners	03-05	MT
BIMI International Medical, Inc. Announces Management Appointments	01-05	CI
BIMI International Medical, Inc. has Changed its Name to BIMI Holdings Inc	01-05	CI
BIMI International Medical, Inc. announced that it has received $3 million in funding	01-01	CI
BIMI International Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	12-19	CI
BIMI International Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11-22	CI
BIMI International Medical Gets Nasdaq Non-Compliance Notice for Late Quarterly Report	24/08/23	MT
Earnings Flash (BIMI) BIMI INTERNATIONAL MEDICAL Reports Q1 Revenue $3.2M	22/05/23	MT
BIMI International Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	19/05/23	CI
BIMI International Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	04/05/23	CI
BIMI International Medical, Inc. Auditor Raises 'Going Concern' Doubt	03/05/23	CI
BIMI International Medical Receives Non-Compliance Notice From Nasdaq	20/04/23	MT
BIMI International Medical Inc. Completed the acquisition of Phenix Bio Inc. from Fnu Oudom for $7.13 million.	14/03/23	CI
BIMI International Medical, Inc. announced that it expects to receive $3 million in funding	26/02/23	CI
Yu Xiang entered into an agreement to 87% stake in Chaohu Zhongshan Minimally Invasive Hospital from BIMI International Medical, Inc..	03/01/23	CI
Weaker-Than-Expected Retail Sales, Hawkish Fed Send US Stock Futures Sharply Lower	15/12/22	MT
Top Premarket Decliners	15/12/22	MT
BIMI International Medical Inc. cancelled the acquisition of Bengbu Mali Maternity Hospital from Renbao Chen and others.	14/12/22	CI
BIMI International Medical Climbing in Late Trade After Contingent Payments From 2020 Purchase Returned	13/12/22	MT
BIMI International to Effect 1-for-10 Reverse Stock Split; Shares Rise After-Hours	08/12/22	MT
BIMI International Medical, Inc. announced that it has received $2 million in funding	05/12/22	CI
BIMI International Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	21/11/22	CI
BIMI International Medical, Inc. cancelled the transaction announced on November 17, 2021	16/11/22	CI
BIMI International Agrees to Sell Chonqing Zhuoda Pharmaceutical in China; to Focus on Growth in US	24/10/22	MT
Three citizens of China entered into an agreement to acquire Chongqing Zhuoda Pharmaceutical Co, Ltd. from BIMI International Medical, Inc..	23/10/22	CI

BIMI Holdings Inc., formerly BIMI International Medical Inc., is a healthcare products and services provider. The Company offers a range of healthcare products and related services in the United States and Asia. The Company operates in four segments: wholesale pharmaceuticals, wholesale medical devices, medical services and retail pharmacy. The wholesale pharmaceuticals segment includes supplying prescription and over the counter (OTC) medicines, traditional Chinese medicines (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. The wholesale medical devices segment distributes medical devices, including medical consumables, to private clinics, hospitals, third party pharmacies and other medical device dealers. The retail pharmacy segment sells prescription and OTC medicines, TCM, healthcare supplies and sundry items to retail customers through its directly owned pharmacies and authorized retail stores.

Sector

Pharmaceuticals

Calendar

12/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
BIMI HOLDINGS INC.	-36.99%	17.64M
MCKESSON CORPORATION	+21.01%	73.38B
CARDINAL HEALTH, INC.	-2.75%	24.13B
SINOPHARM GROUP CO. LTD.	+7.58%	8.78B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+10.52%	8.59B
HUADONG MEDICINE CO., LTD	-19.56%	8.06B
H. LUNDBECK A/S	+14.16%	5.26B
EBOS GROUP LIMITED	-0.93%	4.21B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+12.13%	4.17B
GALENICA AG	-2.54%	3.89B